https://www.selleckchem.com/pr....oducts/cevidoplenib-
Since several pathways are normally altered in malignant gliomas, better outcomes may result from combining multi-target strategies rather than targeting a single effector. In the last years, several preclinical studies with different types of peptides moved in this direction, providing promising results in murine models of disease and opening new perspectives for peptide applications in the treatment of high-grade brain tumors.Capacitive Micromachined Ultrasonic Transducer (CMUT) is a promising ultrasonic transducer in
Curtir
Comentario
Compartilhar
